Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
Clinical trial NCT07034742 · RECRUITING
Trial details
- NCT number
- NCT07034742
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-01-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.